ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma.

Aaron R Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.